Loading patent…
AssigneeShenzhen ScienCare Pharmaceutical Co., Ltd.
InventorsWei Qu, Yamin Huang, Shugui Yin, Tao Zhang, Xiaoge Zhao, Yunhua Wang, Anni Guo, Xinmin Qiu
Estimating the term…
A pharmaceutical composition for preventing relapse into cannabis use, and related therapeutic uses are disclosed. The pharmaceutical composition includes an active pharmaceutical ingredient of naltrexone and risperidone, which may be used for treating a patient suffering from a cannabis addiction disorder or any condition or symptom associated with the cannabis addiction disorder, alleviating adverse symptoms caused by cannabis addiction, and preventing relapse into cannabis use in a patient recovering from the treatment of cannabis abuse addiction.
A method for maintaining cannabis abstinence, or preventing relapse into cannabis use in a subject that has abstained from cannabis use, comprising administering to the subject naltrexone and risperidone.
A pharmaceutical composition comprising naltrexone and risperidone at a weight ratio of (5-30):
Dependencies are inferred from the claim text.